InflaRx (IFRX) Current Taxes (2017 - 2019)
InflaRx (IFRX) posted Current Taxes of -$228304.4 for Q3 2019, down 9.83% sequentially from -$207873.2 in Q2 2019, and down 106.61% YoY from $3.5 million in Q3 2018.
InflaRx (IFRX) Current Taxes (2017 - 2019) Analysis & Trends
InflaRx has reported Current Taxes for 3 years, with the latest figure at -$228304.4 in Q3 2019.
- Quarterly Current Taxes fell 106.61% year-over-year to -$228304.4 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was -$228304.4 (down 106.61% YoY) and the FY2018 annual result came in at $366212.4, up 1180.91% from the prior year.
- Current Taxes eased to -$228304.4 in Q3 2019 per IFRX's latest filing, from -$207873.2 in the prior quarter.
- Over five years, Current Taxes peaked at $3.5 million in Q3 2018 and troughed at -$228304.4 in Q3 2019.
- A 3-year average of $601104.4 and a median of -$2386.9 in 2018 frame the typical range for Current Taxes.
- The sharpest annual moves came in 2018 and 2019: Current Taxes surged 1101.47% in 2018, then tumbled 8608.96% in 2019.
- Over 3 years, Current Taxes stood at -$35323.0 in 2017, then soared by 1101.47% to $353750.7 in 2018, then plunged by 164.54% to -$228304.4 in 2019.
- According to Business Quant data, Current Taxes over the past three periods registered -$228304.4, -$207873.2, and $872931.0 for Q3 2019, Q2 2019, and Q1 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | InflaRx | 140.30 Mn | -43.96 Mn | 2.74 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -228,304.38 |
| Jun 30, 2019 | -207,873.23 |
| Mar 31, 2019 | 872,930.97 |
| Dec 31, 2018 | 353,750.71 |
| Sep 30, 2018 | 3.45 Mn |
| Jun 30, 2018 | -2,386.89 |
| Dec 31, 2017 | -35,322.98 |